Latest Japan News

X2M Connect is accelerating its transition to a high-margin SaaS model while trimming debt and growing its footprint across Asia-Pacific and the Middle East.

NH3 Clean Energy’s WAH2 project is projected to deliver substantial economic and environmental benefits, including a $7.3 billion GDP uplift and 13.5 million tonnes of CO2 emissions avoided, underpinning its push for government-backed concessional financing.

Critical Resources has confirmed significant greisen-hosted tungsten mineralisation at Granite Creek, boosting its exploration priority in a market where tungsten prices have surged over eightfold since early 2025. Assay results from ongoing New Zealand field programs are due mid-2026.

Hastings Technology Metals secures 49% of a Thai hydromet plant, aiming for Q4 2026 production using African monazite feedstock, setting a path for early cash flow ahead of Yangibana.

Recce Pharmaceuticals bolsters its clinical and commercial pipeline with a $5.3 million AUD R&D tax rebate, a second U.S. Army research agreement for its RECCE 327 Gel, and a key patent granted in Brazil, while progressing Phase 3 trials in Indonesia.

Evion Group has secured key approvals from Madagascar’s Ministry of Mines to convert exploration permits into mining permits for its Maniry Graphite Project, backed by significant EU funding and US trade initiatives. Meanwhile, its Indian joint venture progresses a major graphite plant expansion to meet growing demand.

Zimi Limited posted 14% revenue growth and landed its biggest project order to date with Homecorp, while slashing operating costs and launching an AI sales agent.

Ioneer Ltd has raised US$50 million to push forward its fully permitted Rhyolite Ridge lithium-boron project in Nevada, buoyed by a federal court ruling upholding project approvals and ongoing strategic partner discussions.

Eagle Mountain Mining has finalised a joint venture with Nittetsu Mining for the Oracle Ridge copper project, extinguishing a US$7.25 million loan and securing US$16.5 million in additional funding from Nittetsu.

Control Bionics progresses its scalable distributor-led model in North America, inks a strategic US partnership for iOS speech devices, and gains German reimbursement eligibility for NeuroNode, while managing cash flow amid NDIS delays.

xReality Group delivered a standout Q3 FY26 with a 62% jump in cash receipts and a new Mixed Reality sale to the US Department of Defense, underpinning its growing Operator XR platform.

Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.